GLPG CAR T-cell therapy
LTF-CL-001
Phase 3 gene_therapy active
Quick answer
GLPG CAR T-cell therapy for Hematological Malignancies is a Phase 3 program (gene_therapy) at Lakefront Biotherapeutics NV with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Hematological Malignancies
- Phase
- Phase 3
- Modality
- gene_therapy
- Status
- active